{"id":"NCT00516737","sponsor":"Organon and Co","briefTitle":"Study to Test Rizatriptan in the Early Treatment of Acute Migraine (0462-081)","officialTitle":"A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Factorial Design Clinical Trial to Study the Efficacy and Safety of MK0462 / Rizatriptan 10 mg for the Early Treatment of Acute Migraine","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-10-03","primaryCompletion":"2008-04-08","completion":"2008-04-08","firstPosted":"2007-08-15","resultsPosted":"2009-04-14","lastUpdate":"2024-04-22"},"enrollment":207,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Migraine"],"interventions":[{"type":"DRUG","name":"Comparator: rizatriptan benzoate","otherNames":["MK0462"]},{"type":"DRUG","name":"Comparator: Placebo","otherNames":[]}],"arms":[{"label":"1","type":"EXPERIMENTAL"},{"label":"2","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to test the effectiveness of rizatriptan benzoate in the early treatment of an acute migraine attack.","primaryOutcome":{"measure":"Number of Participants Who Are Pain Free at 2 Hours Post-Dose","timeFrame":"2 hours post-dose","effectByArm":[{"arm":"Rizatriptan 10 mg ODT","deltaMin":61,"sd":null},{"arm":"Placebo","deltaMin":27,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":3},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["19472447"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":92},"commonTop":["Dizziness","Hyperchlorhydria","Nausea","Fatigue","Feeling cold"]}}